v3.26.1
Cover - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Mar. 16, 2026
Jun. 30, 2025
Document Type 10-K      
Amendment Flag false      
Document Annual Report true      
Document Transition Report false      
Document Period End Date Dec. 31, 2025      
Document Fiscal Period Focus FY      
Document Fiscal Year Focus 2025      
Current Fiscal Year End Date --12-31      
Entity File Number 001-40943      
Entity Registrant Name BIOFRONTERA INC.      
Entity Central Index Key 0001858685      
Entity Tax Identification Number 47-3765675      
Entity Incorporation, State or Country Code DE      
Entity Address, Address Line One 660 Main Street      
Entity Address, Address Line Two 1st Floor      
Entity Address, City or Town Woburn      
Entity Address, State or Province MA      
Entity Address, Postal Zip Code 01801      
City Area Code (781)      
Local Phone Number 245-1325      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company true      
Elected Not To Use the Extended Transition Period false      
Entity Shell Company false      
Entity Public Float       $ 6.9
Entity Common Stock, Shares Outstanding     11,648,323  
Documents Incorporated by Reference [Text Block] Portions of the registrant’s Proxy Statement relative to the Annual Meeting of Stockholders for the year ended December 31, 2025 are incorporated by reference into Part III of this Form 10-K.      
ICFR Auditor Attestation Flag false      
Document Financial Statement Error Correction false      
Entity Listing, Par Value Per Share $ 0.001      
Auditor Firm ID 199 688    
Auditor Opinion [Text Block] We have audited the accompanying consolidated balance sheet of Biofrontera Inc. (the “Company”) as of December 31, 2025, the related consolidated statements of operations, stockholders’ equity and cash flows for the year ended December 31, 2025, and the related notes (collectively referred to as the “financial statements”). In our opinion, based on our audit, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the year ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America      
Auditor Name CBIZ CPAs P.C Marcum llp    
Auditor Location Morristown, New Jersey Morristown, New Jersey    
Common stock, par value $0.001 per share [Member]        
Title of 12(b) Security Common Stock, par value $0.001 per share      
Trading Symbol BFRI      
Security Exchange Name NASDAQ      
Warrants For Common Stock [Member]        
Title of 12(b) Security Warrants for common stock      
Trading Symbol BFRIW      
Security Exchange Name NASDAQ